Recall D-0474-2026

US Class II Ongoing · initiated 2026-03-19

Recalling firm

Teva Pharmaceuticals USA, Inc, NJ

Product

Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3510-04 carton, NDC 0591-3510-54 pouch

Reason for recall

CGMP Deviations: use of an unapproved raw material

← All recalls